2C-EF-FLY
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
2C-EF-FLY is a psychedelic drug of the phenethylamine, 2C, and FLY families. It is the FLY (benzodifuran) derivative of 2C-EF and is a fluorinated derivative of 2C-E-FLY. The in-vitro metabolism of 2C-EF-FLY and its monoamine oxidase (MAO) interactions have been described.
2C-EF-FLY produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. It showed around half the potency of 2C-B-FLY and 2C-E-FLY in this assay, but was slightly more potent than 2C-I-FLY. 2C-EF-FLY was first described in the scientific literature by Lea Wagmann and colleagues in 2018 or 2019.
It has been described as a novel designer drug.
2C-EF-FLY is a psychedelic drug of the phenethylamine, 2C, and FLY families. It is the FLY (benzodifuran) derivative of 2C-EF and is a fluorinated derivative of 2C-E-FLY. The in-vitro metabolism of 2C-EF-FLY and its monoamine oxidase (MAO) interactions have been described.
2C-EF-FLY produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. It showed around half the potency of 2C-B-FLY and 2C-E-FLY in this assay, but was slightly more potent than 2C-I-FLY. 2C-EF-FLY was first described in the scientific literature by Lea Wagmann and colleagues in 2018 or 2019.
It has been described as a novel designer drug.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371211864 under CC BY-SA 4.0; modifications have been made.